Prostate Cancer - Results from #1520

Long-term outcomes of pelvic-fascia sparing robotic-assisted radical prostatectomy versus standard technique: Superior urinary function and quality of life without compromising oncologic efficacy in a single-surgeon series. January 15, 2024

Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. January 15, 2024

Detection of Extracellular Vesicle-Derived RNA as Potential Prostate Cancer Biomarkers: Role of Cancer-type SLCO1B3 and ABCC3. January 15, 2024

Temporal trends in cardiovascular burden among patients with prostate cancer receiving androgen deprivation therapy: a population-based cohort study. January 12, 2024

Adverse cardiovascular effect following gonadotropin-releasing hormone antagonist versus GnRH agonist for prostate cancer treatment: A systematic review and meta-analysis. January 12, 2024

Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation. January 12, 2024

Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer. January 12, 2024

Non-invasive detection of neuroendocrine prostate cancer through targeted cell-free DNA methylation. January 12, 2024

Genomic classifiers and prognosis of localized prostate cancer: a systematic review. January 12, 2024

Clinical Positron Emission Tomography/Computed Tomography: Quarter-Century Transformation of Prostate Cancer Molecular Imaging. January 12, 2024

Radiation Therapy Summary of the AUA/ASTRO Guideline on Clinically Localized Prostate Cancer. January 11, 2024

The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging of Selected Renal Tumours: Initial Experience in a Multicentre Cohort. January 11, 2024

Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy? January 11, 2024

Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer. January 11, 2024

Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancer. January 11, 2024

Role of Radiotherapy and Hormone Therapy in Patients with Node-Positive Locally Advanced Prostate Cancer. January 11, 2024

Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer. January 10, 2024

Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis. January 10, 2024

Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients. January 10, 2024

A population-based study of cardiovascular disease mortality risk in US cancer patients. January 10, 2024

Page 77 of 1436